Breaking News

Is a Long-Lasting Japanese Gel Manicure Worth Trying for Damaged Nails? Portia Hogg Promoted to Information Technology Director at Duncanville Juventus Successfully Secure Everton Midfielder in Latest Summer Transfer Deal Boone County under drug overdose alert by Northern Kentucky Health Department Female sports enthusiasts rejoice as NWSL selects CPKC Stadium for championship game

The beginning of a new semester brought hope for a better future, as the first day of July marked the start of this new academic year. The Helsinki Stock Exchange saw an increase in its general index by 1.4 percent, closing at 10,076.34 points. The most traded stock of the day was Nordea, with almost 70 million shares changing hands. Nordea’s share price increased by approximately 2.7 percent. On the other hand, Nightingale Health experienced a decline of about 12.2 percent in its stock value.

Nokia announced that it had started production of its first tire at a new factory under construction in Romania. The company reported that the project was progressing on schedule and within budget, with commercial tire production expected to begin in early 2025. The factory is estimated to employ around 500 people and have a production capacity of six million tires. Nokia’s shares rose by approximately 2.1 percent in response to this news.

Orion raised its guidance for turnover and operating profit after entering into an exclusive license agreement with MSD. This agreement is expected to positively impact Orion’s financials in the coming quarters, leading to a 4.0 percent increase in its stock price.

Afarak reported lower EBITDA and turnover for the first half of 2024 compared to the previous year, resulting in an 8.0 percent decline in its share price.

Tietoevry extended the sale schedule for its Tech Services business, with more details expected to be provided in the third-quarter results report.

Kemira made its entry into the activated carbon market with its acquisition of Noritin’s reactivation business, causing a rise of approximately 1.0 percent in Kemira’s stock price.

Lemonsoft acquired software developer Applirentin, resulting in a negative impact on Lemonsoft’s stock price by -2.4 percent.

Herantis Pharma received funding from the Michael J Fox Foundation for Parkinson’s Research for a clinical trial, causing a decline of -3

Leave a Reply